Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia

被引：2
|
作者：
El Kinge, Abdul Rahman
Hatourn, Hassan A.
Mahfouz, Rami A. [2 ]
Otrock, Zaher K. [2 ]
Jabbour, Elias [3 ]
Kantarjian, Hagop [3 ]
Bazarbachi, Ali [1 ]
机构：
[1] Amer Univ Beirut, Med Ctr, Dept Internal Med, Bone Marrow Transplantat Program, Beirut, Lebanon
[2] Amer Univ Beirut, Med Ctr, Dept Pathol & Lab Med, Beirut, Lebanon
[3] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
来源：
LEUKEMIA RESEARCH | 2009年 / 33卷 / 04期
关键词：
ACUTE MYELOGENOUS LEUKEMIA; RELAPSE; CHEMOTHERAPY; PROPOSAL;
D O I：
10.1016/j.leukres.2008.05.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：565 / 566
页数：2
相关论文
共 50 条
  • [1] Gemtuzumab ozogamicin for acute myeloid leukemia
    Appelbaum, Frederick R.
    Bernstein, Irwin D.
    BLOOD, 2017, 130 (22) : 2373 - 2376
  • [2] Optimizing survival outcomes with post-remission therapy in acute myeloid leukemia
    Medeiros, Bruno C.
    Chan, Steven M.
    Daver, Naval G.
    Jonas, Brian A.
    Pollyea, Daniel A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (07) : 803 - 811
  • [3] Optimal dosing of cytarabine in induction and post-remission therapy of acute myeloid leukemia
    Walter, Roland B.
    Appelbaum, Frederick R.
    Estey, Elihu H.
    LEUKEMIA, 2021, 35 (02) : 295 - 298
  • [4] Post-remission therapy in acute myeloid leukemia: Are we ready for an individualized approach?
    Derman, Benjamin A.
    Larson, Richard A.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2019, 32 (04)
  • [5] Antibody-based therapy of acute myeloid leukemia with gemtuzumab ozogamicin
    Cowan, Andrew J.
    Laszlo, George S.
    Estey, Elihu H.
    Walter, Roland B.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2013, 18 : 1312 - 1335
  • [6] Gemtuzumab ozogamicin in non-acute promyelocytic acute myeloid leukemia
    Huetter, Marie-Luise
    Schlenk, Richard F.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (10) : 1369 - 1380
  • [7] High-dose idarubicin plus busulfan as conditioning regimen to autologous stem cell transplantation: Promising post-remission therapy for acute myeloid leukemia in first complete remission?
    Hong, Ming
    Miao, Kou-Rong
    Zhang, Run
    Lu, Hua
    Liu, Peng
    Xu, Wei
    Chen, Li-Juan
    Zhang, Su-Jiang
    Wu, Han-Xin
    Qiu, Hong-Xia
    Li, Jian-Yong
    Qian, Si-Xuan
    MEDICAL ONCOLOGY, 2014, 31 (06)
  • [8] Gemtuzumab ozogamicin in acute myeloid leukemia: act 2, with perhaps more to come
    Hitzler, Johann
    Estey, Elihu
    HAEMATOLOGICA, 2019, 104 (01) : 7 - 9
  • [9] The addition of gemtuzumab ozogamicin to chemotherapy in adult patients with acute myeloid leukemia
    Kell, Jonathan
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (04) : 377 - 382
  • [10] A phase 2 trial of azacitidine and gemtuzumab ozogamicin therapy in older patients with acute myeloid leukemia
    Nand, Sucha
    Othus, Megan
    Godwin, John E.
    Willman, Cheryl L.
    Norwood, Thomas H.
    Howard, Dianna S.
    Coutre, Steven E.
    Erba, Harry P.
    Appelbaum, Frederick R.
    BLOOD, 2013, 122 (20) : 3432 - 3439
12345